Literature DB >> 2096511

Infection with Pneumocystis carinii is prevalent in healthy Gambian children.

A E Wakefield1, T J Stewart, E R Moxon, K Marsh, J M Hopkin.   

Abstract

Pneumocystis pneumonia is rarely identified in the many immunosuppressed individuals with acquired immune deficiency syndrome (AIDS) and malnutrition in Africa. To test whether infection with Pneumocystis carinii occurs in the continent we conducted a comparative serological study, measuring by enzyme-linked immunosorbent assay antibodies to the parasite in 150 healthy young individuals from both Britain and the Gambian savanna. The prevalence of significant titres of antibody to P. carinii steadily increased with age and included more than 70% of both populations by 8 years of age. Infection with P. carinii is, therefore, common in the Gambia. Thus opportunistic pneumocystis pneumonia may be an important but largely unrecognized disease in the continent, though its impact is probably diminished by the prevalence of fatal tuberculous infection, particularly in the AIDS population.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Age Factors; Biology; Demographic Factors; Developed Countries; Developing Countries; Diseases; England; English Speaking Africa; Europe; Examinations And Diagnoses; Gambia; Hematologic Tests; Hematological Effects; Hemic System; Hiv Infections; Immunoglobulin Alterations; Laboratory Examinations And Diagnoses; Laboratory Procedures; Measurement; Northern Europe; Parasitic Diseases; Physiology; Population; Population Characteristics; Prevalence; Pulmonary Effects; Research Methodology; Research Report; United Kingdom; Viral Diseases; Western Africa

Mesh:

Substances:

Year:  1990        PMID: 2096511     DOI: 10.1016/0035-9203(90)90087-u

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  26 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

Review 2.  Infectious diseases and AIDS.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

Review 3.  Update on the diagnosis and treatment of Pneumocystis pneumonia.

Authors:  Eva M Carmona; Andrew H Limper
Journal:  Ther Adv Respir Dis       Date:  2010-08-24       Impact factor: 4.031

Review 4.  AIDS and the lung: update 1992. 1. Pneumocystis carinii pneumonia.

Authors:  R F Miller; D M Mitchell
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

5.  Sterols of Pneumocystis carinii hominis organisms isolated from human lungs.

Authors:  E S Kaneshiro; Z Amit; J Chandra; R P Baughman; C Contini; B Lundgren
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

6.  High transient colonization by Pneumocystis jirovecii between mothers and newborn.

Authors:  Cristian Vera; Yudy A Aguilar; Lázaro A Vélez; Zulma Vanessa Rueda
Journal:  Eur J Pediatr       Date:  2017-09-14       Impact factor: 3.183

Review 7.  Tropical respiratory medicine. 1. Pulmonary infections in the tropics: impact of HIV infection.

Authors:  C L Daley
Journal:  Thorax       Date:  1994-04       Impact factor: 9.139

8.  Primary pneumocystis infection in infants hospitalized with acute respiratory tract infection.

Authors:  Hans Henrik Larsen; Marie-Louise von Linstow; Bettina Lundgren; Birthe Høgh; Henrik Westh; Jens D Lundgren
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

9.  Healthcare worker occupation and immune response to Pneumocystis jirovecii.

Authors:  Renuka Tipirneni; Kieran R Daly; Leah G Jarlsberg; Judy V Koch; Alexandra Swartzman; Brenna M Roth; Peter D Walzer; Laurence Huang
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

Review 10.  A new name (Pneumocystis jiroveci) for Pneumocystis from humans.

Authors:  James R Stringer; Charles B Beard; Robert F Miller; Ann E Wakefield
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.